These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2374924)

  • 21. Immune modulation strategies in T cell mediated autoimmune diseases-relevance to IDDM.
    Mathieson PW
    J Pediatr Endocrinol Metab; 1996 Mar; 9 Suppl 1():133-8. PubMed ID: 8887164
    [No Abstract]   [Full Text] [Related]  

  • 22. The taming of the shrew? The immunology of corneal transplantation.
    Pleyer U; Schlickeiser S
    Acta Ophthalmol; 2009 Aug; 87(5):488-97. PubMed ID: 19664109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dendritic cells: orchestration of the immune response].
    Martinon-Ego C; Berthier R
    Ann Biol Clin (Paris); 2000; 58(5):541-56. PubMed ID: 11022098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerogenic antibodies and fusion proteins to prevent graft rejection and treat autoimmunity.
    Chatenoud L
    Mol Med Today; 1998 Jan; 4(1):25-30. PubMed ID: 9494967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunosuppression by means of antilymphocyte serums in humans].
    Revillard JP
    Nouv Rev Fr Hematol; 1972; 12(2):129-37. PubMed ID: 4264610
    [No Abstract]   [Full Text] [Related]  

  • 26. Psoriasis as a T cell-mediated autoimmune disease.
    Barker JN
    Hosp Med; 1998 Jul; 59(7):530-3. PubMed ID: 9798540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-time monitoring of immune responses.
    Wieder ED
    Cytotherapy; 2002; 4(4):347-52. PubMed ID: 12396835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective targets for immunotherapy in autoimmune disease.
    Yang XD; Tisch R; McDevitt HO
    Chem Immunol; 1995; 60():20-31. PubMed ID: 7857527
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune therapy for autoimmune diseases.
    Steinman L
    Science; 2004 Jul; 305(5681):212-6. PubMed ID: 15247472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
    van Elsas A; Hurwitz AA; Allison JP
    J Exp Med; 1999 Aug; 190(3):355-66. PubMed ID: 10430624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell tolerance: models for clinical application to allergy and autoimmunity.
    Schad VC
    Chem Immunol; 1994; 58():193-205. PubMed ID: 8011152
    [No Abstract]   [Full Text] [Related]  

  • 32. Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infections.
    Pentcheva-Hoang T; Corse E; Allison JP
    Immunol Rev; 2009 May; 229(1):67-87. PubMed ID: 19426215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormonal approaches to immunotherapy of autoimmune disease.
    Talal N; Ahmed SA; Dauphinee M
    Ann N Y Acad Sci; 1986; 475():320-8. PubMed ID: 3491566
    [No Abstract]   [Full Text] [Related]  

  • 34. How the immune system achieves self-nonself discrimination during adaptive immunity.
    Jiang H; Chess L
    Adv Immunol; 2009; 102():95-133. PubMed ID: 19477320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoregulation rather than immunosuppression for prevention and treatment of autoimmune disorders.
    Slavin S
    Transplant Proc; 1996 Dec; 28(6):3021-2. PubMed ID: 8962172
    [No Abstract]   [Full Text] [Related]  

  • 36. Immune mechanisms of long-term graft acceptance.
    Hutchinson IV
    Adv Nephrol Necker Hosp; 1996; 25():17-38. PubMed ID: 8717618
    [No Abstract]   [Full Text] [Related]  

  • 37. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigen-specific immunosuppression: oral tolerance for the treatment of autoimmune disease.
    Hafler DA; Weiner HL
    Chem Immunol; 1995; 60():126-49. PubMed ID: 7857525
    [No Abstract]   [Full Text] [Related]  

  • 39. [Mechanisms of immune homeostasis: implications for the pathogenesis of autoimmune diseases].
    Kroemer G
    Wien Klin Wochenschr; 1992; 104(24):735-43. PubMed ID: 1288017
    [No Abstract]   [Full Text] [Related]  

  • 40. Thymic hormone in the treatment of cancer.
    Dardeene M; Bach JF
    Prog Clin Biol Res; 1989; 288():363-82. PubMed ID: 2654955
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.